Formulation Design for Tablets and an Introduction to your new All-in-One Tableting Solution
Coprocessed excipients provide solutions to simplify formulations and reduce manufacturing complexity, saving you time and money.
Kollitab™ DC 87 L is BASF’s new coprocessed excipient combining a filler, binder, disintegrant and lubricant, for direct compression tableting.
Learn what the formulation and parameter targets are to optimize direct compression formulations, and how to accelerate development with BASF’s new all-in-one fit-for-purpose tableting solution.
Key Learnings:
- Critical process parameter targets for tableting processes
- Formulation considerations with individual and coprocessed excipients
- Industry trends towards simplified formulations and less complex manufacturing
- Fit-for-purpose ingredients for superior flowability, fast disintegration, and high tablet strength at low compression forces